Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
FYB.DEthis companyFormycon AG	€14.50	-6.99×	1.13×	10.17×	-161.19×	-115.1%	8.0%	-66.0%	-145.5%	-16.2%	-3.1%	-9.8%	0.02×	24.32×	-9.35×	2.33×	0.0%	4	0.45	3	B
BNN.DEBRAIN Biotech AG	€2.62	-4.04×	25.87×	0.96×	-15.71×	-248.0%	4.0%	-17.1%	-23.7%	-637.8%	-15.9%	-22.6%	13.05×	-4.28×	-3.86×	1.42×	0.0%	2	0.9	2	C
HPHA.DEHeidelberg Pharma AG	€2.19	-3.16×	-12.31×	92.22×	-2.7×	-89.9%	-81.4%	-3255.4%	-2901.1%	387.3%	-175.5%	-23.6%	-0.11×	0.31×	-9,656.78×	2.53×	0.0%	5	-12.85	2	C
ILM1.DEMedios AG	€11.40	23.74×	0.71×	0.17×	5.9×	317.3%	4.4%	2.0%	0.7%	3.0%	3.1%	10.2%	0.37×	1.34×	2.18×	1.9×	0.0%	6	3.32	3	B+
M12.DEM1 Kliniken AG	€18.78	15.97×	2.94×	0.97×	8.03×	90.6%	13.0%	10.1%	6.1%	18.5%	15.8%	10.7%	0.09×	-0.68×	23.87×	2.82×	2.6%	6	11.72	4	A
NPNP5.DENewron Pharmaceuticals S.p.A.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	6.4×	1.82×	0.96×	1.6×	0.3%	4.2%	-7.6%	-11.5%	10.7%	-6.4%	-6.2%	0.23×	-0.18×	-0.84×	2.21×	0.0%	6	2.11	3	—